Abbott Labs (ABT) Q3 Beats on Bottom Line, Misses on Top; Raises Low End of FY10 Outlook
Tweet Send to a FriendGet Alerts ABT Hot Sheet
Trade ABT Now!
Abbott Labs (NYSE: ABT) Reports Q3 operating EPS of $1.05, 1 cent better than the analyst estimate of $1.04. Revenue for the quarter was $8.675 billion, which compares to the estimate of $8.91 billion.
Raises low end of its prior FY10 guidance range: from $4.13-$4.18 to $4.16-$4.18, vs. the consensus of $4.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Raises low end of its prior FY10 guidance range: from $4.13-$4.18 to $4.16-$4.18, vs. the consensus of $4.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Infoblox (BLOX) Tops Q3 EPS by 5c; Issues Outlook
- Nordson Corp (NDSN) Reports In-Line Q2 EPS, Q3 Guidance Falls Short
Create E-mail Alert Related Categories
Earnings, Guidance, Hot List
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
